Guenter Auerswald
Guenter Auerswald has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Carolin Moorthi
Coagulation Centre, Bremen Central Clinic, GeNo Ltd., Parent-Child-Centre Prof. Hess, Bremen, Germany
2 shared publications Christine Heller
Department of Paediatrics, Paediatric Haemophilia Centre, Goethe University, University Hospital Frankfurt, Frankfurt/Main, Germany
2 shared publicationsCornelia Wermes
Department of Paediatric Haematology and Oncology, Hanover Medical School, Hanover, Germany
2 shared publications- Freimut Schilling
Children´s Hospital, Olgahospital, Stuttgart, Germany
2 shared publications - Ronald Fischer
D'Or Institute for Research and Education (IDOR)
2 shared publications - Susan Halimeh
Rhine Ruhr Coagulation Centre Duisburg Germany
2 shared publications
Latest Publications
- Open Access
- 28 November 2025
- Published by Wiley in Haemophilia
- Vol. 32 (1) , 143-154
Health‐Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL‐QoL Study
Introduction: Assessment of health‐related quality of life (HRQoL) is relatively new in von Willebrand disease (VWD). So far, generic questionnaires have mainly been used for HRQoL assessment in VWD. Aims: To assess generic and disease‐specific HRQoL in adult VWD patients and compare HRQoL with the general German population. Methods: Patients presenting with a personal or family history of bleeding and von Willebrand factor (VWF)‐specific laboratory parameters were enrolled in the WIL‐QoL study. HRQoL was assessed with generic (SF‐36) and disease‐specific (VWD‐QoL) questionnaires. Descriptive and inferential statistical procedures were applied based on a significance level at α ≤ 5%. Results: In the retrospective, multicentre WIL‐QoL study, HRQoL and clinical data in 120 adults with VWD (one adolescent completed the adult questionnaire) from 10 centres in Germany were collected. Compared to the corresponding age group in the general German population, female VWD patients had significantly worse HRQoL in all SF‐36 domains and male patients only in the ‘physical functioning’ domain. In the VWD‐QoL, highest impairments were seen in all VWD patients in the domains ‘other physicians’, ‘treatment’ and ‘sport & leisure’. VWD patients with a more significant disease burden, such as a bleeding score ≥ 9 ( p < 0.0001), long‐term prophylaxis ( p = 0.003), and VWD‐type 3 ( p = 0.022), reported significantly worse HRQoL. No HRQoL differences were seen between male and female VWD patients. Conclusion: Female VWD patients showed significant impairments in their HRQoL compared to the age group‐related general population. Compared to SF‐36, the VWD‐QoL identified stronger significant HRQoL differences in most VWD subgroups, confirming the impact of bleeds.
- 28 November 2025
- Published by Wiley in Haemophilia
- Vol. 32 (1) , 143-154
Open AccessHealth‐Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL‐QoL Study
Introduction: Assessment of health‐related quality of life (HRQoL) is relatively new in von Willebrand disease (VWD). So far, generic questionnaires have mainly been used for HRQoL assessment in VWD. Aims: To assess generic and disease‐specific HRQoL in adult VWD patients and compare HRQoL with the general German population. Methods: Patients presenting with a personal or family history of bleeding and von Willebrand factor (VWF)‐specific laboratory parameters were enrolled in the WIL‐QoL study. HRQoL was assessed with generic (SF‐36) and disease‐specific (VWD‐QoL) questionnaires. Descriptive and inferential statistical procedures were applied based on a significance level at α ≤ 5%. Results: In the retrospective, multicentre WIL‐QoL study, HRQoL and clinical data in 120 adults with VWD (one adolescent completed the adult questionnaire) from 10 centres in Germany were collected. Compared to the corresponding age group in the general German population, female VWD patients had significantly worse HRQoL in all SF‐36 domains and male patients only in the ‘physical functioning’ domain. In the VWD‐QoL, highest impairments were seen in all VWD patients in the domains ‘other physicians’, ‘treatment’ and ‘sport & leisure’. VWD patients with a more significant disease burden, such as a bleeding score ≥ 9 ( p < 0.0001), long‐term prophylaxis ( p = 0.003), and VWD‐type 3 ( p = 0.022), reported significantly worse HRQoL. No HRQoL differences were seen between male and female VWD patients. Conclusion: Female VWD patients showed significant impairments in their HRQoL compared to the age group‐related general population. Compared to SF‐36, the VWD‐QoL identified stronger significant HRQoL differences in most VWD subgroups, confirming the impact of bleeds.
- 19 November 2025
- Published by Wiley in Haemophilia
- Vol. 32 (1) , 174-184
Clinical, Obstetric‐Gynaecological and HRQoL Data of Female VWD Patients in the WIL‐QoL Study
Introduction: Von Willebrand disease (VWD) is one of the most common hereditary disorders of primary haemostasis. Females with VWD often report heavy menstrual bleeding (HMB) that can significantly impact health‐related quality of life (HRQoL). Aim: To analyse clinical and HRQoL data of females with VWD from the WIL‐QoL study. Methods: Clinical and obstetric‐gynaecological data were collected by a physician‐led clinical questionnaire and HRQoL data via a patient‐reported VWD‐specific questionnaire (VWD‐QoL). Results: Data on menstruation were available from 113 females with VWD (15 post‐menarche girls [mean age 14.8 ± 1.7 years] and 98 women [mean age 37.8 ± 12.6 years]). HMB (defined as increased [simultaneous use/replacement of sanitary pads/tampons every 1–2 h] and/or prolonged [>7 days] menstrual bleeding) was reported in 85% and 77% of girls and women, respectively. Of 72 women who became pregnant, 31 experienced bleeding during pregnancy (3 women had missing data) and 32 women reported at least one miscarriage (44%). Overall, 12/96 women (13%) underwent hysterectomy due to bleeding; these women had more moderate‐to‐severe VWD ( p < .006) and a higher bleeding score ( p < .013) than women who did not undergo hysterectomy. Women still experiencing menstruation ( n = 71) who ‘often/all the time’ self‐reported HMB (HMB‐PRO), pain during menstruation and impairments in everyday‐life activities due to menstruation had significantly worse HRQoL compared with those who ‘never/rarely’ reported these impacts ( p = .004, p < .001 and p < .001, respectively). Women who underwent hysterectomy reported significantly worse HRQoL than those who did not ( p < .007). Conclusion: Female VWD patients experienced substantial disease and HRQoL burden that is further exacerbated by HMB.
- 19 November 2025
- Published by Wiley in Haemophilia
- Vol. 32 (1) , 174-184
Clinical, Obstetric‐Gynaecological and HRQoL Data of Female VWD Patients in the WIL‐QoL Study
Introduction: Von Willebrand disease (VWD) is one of the most common hereditary disorders of primary haemostasis. Females with VWD often report heavy menstrual bleeding (HMB) that can significantly impact health‐related quality of life (HRQoL). Aim: To analyse clinical and HRQoL data of females with VWD from the WIL‐QoL study. Methods: Clinical and obstetric‐gynaecological data were collected by a physician‐led clinical questionnaire and HRQoL data via a patient‐reported VWD‐specific questionnaire (VWD‐QoL). Results: Data on menstruation were available from 113 females with VWD (15 post‐menarche girls [mean age 14.8 ± 1.7 years] and 98 women [mean age 37.8 ± 12.6 years]). HMB (defined as increased [simultaneous use/replacement of sanitary pads/tampons every 1–2 h] and/or prolonged [>7 days] menstrual bleeding) was reported in 85% and 77% of girls and women, respectively. Of 72 women who became pregnant, 31 experienced bleeding during pregnancy (3 women had missing data) and 32 women reported at least one miscarriage (44%). Overall, 12/96 women (13%) underwent hysterectomy due to bleeding; these women had more moderate‐to‐severe VWD ( p < .006) and a higher bleeding score ( p < .013) than women who did not undergo hysterectomy. Women still experiencing menstruation ( n = 71) who ‘often/all the time’ self‐reported HMB (HMB‐PRO), pain during menstruation and impairments in everyday‐life activities due to menstruation had significantly worse HRQoL compared with those who ‘never/rarely’ reported these impacts ( p = .004, p < .001 and p < .001, respectively). Women who underwent hysterectomy reported significantly worse HRQoL than those who did not ( p < .007). Conclusion: Female VWD patients experienced substantial disease and HRQoL burden that is further exacerbated by HMB.